BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. CervoMed Announces Publication of Two…
The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of the world’s #1 cause of disability Rey Pascual, Vivex’s Co-President, added, “The strength of a rigorous sham-controlled trial marks a defining…
The new Somerville, Massachusetts-based company draws on technologies from Cellarity, Etiome, and Empress Therapeutics, and blends them with Flagship's own AI capabilities to create a platform for understanding causal relationships in human biology. Flagship – which was behind the founding of…
The UK Biobank has completed the world's largest whole body imaging project, compiling more than a billion scans from 100,000 volunteers that will now serve as a tool to see what happens in people's bodies as they age and get sick.
Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology MIAMI & SEOUL, South Korea--(BUSINESS WIRE)--$SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) and Lunit Inc. (KRX: 328130) today announced a…
Research presented by LRA, LT, and collaborators will address some of the most significant challenges in lupus, including reducing barriers to clinical trial participation, improving trial design and outcome assessment, evaluating molecular signatures associated with disease severity and treatment response,…
New sites in the UK, France, Sweden, Germany, Italy and Spain will add to the global footprint of the pivotal SIGMA study Study site locations will be listed on ClinicalTrials.gov and updated as finalized. In August 2026, the FDA granted…
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. PharmaTher Builds Portfolio of Personalized,…
The FDA approved GSK's bepirovirsen for adults with chronic hepatitis B on nucleoside therapy, based on phase 3 trials showing 19% functional cure. The FDA has approved Hibsago (bepirovirsen), GSK’s antisense oligonucleotide, for adults with chronic hepatitis B who are already taking…
Lead FDA-track program targets a serious pediatric disease with no FDA-approved treatment and could qualify for a transferable priority review voucher. Highlights Two FDA designation applications submitted for creatine monohydrate in guanidinoacetate methyltransferase (GAMT) deficiency: Orphan Drug Designation (ODD) and…
Drug-industry news from BioSpace, Fierce Pharma, Endpoints, BioPharma Dive, pharmaphorum and BioWorld: trials, approvals, deals and the companies behind new medicines.
An article joins this feed when it matches these terms. Each one is also a search of its own.